
Self-Funded Fixing Healthcare's 528 Billion Dollar Mistake | with Chris Grilli
Sep 3, 2025
Chris Grilli, a pharmacist and genomics expert at RxMapper, dives deep into the staggering $528 billion wasted on medication errors in healthcare. He reveals how personalized, DNA-guided medicine can dramatically reduce these costs and improve patient outcomes with nearly 90% accuracy. Chris shares a personal story that inspired him to develop RxMapper after a family tragedy, and he discusses the powerful role genetics plays in medication efficacy. Tune in to learn how this innovative approach is set to revolutionize healthcare!
AI Snips
Chapters
Transcript
Episode notes
A Personal Tragedy Sparked RxMapper
- Chris's grandmother died from a preventable bleeding complication tied to family genetics.
- That personal tragedy motivated him to build RxMapper to prevent similar adverse drug events.
Target Those Already Struggling On Meds
- Target sequencing to patients actively struggling with medication effectiveness or side effects.
- Use claims data (PBM/TPA) to proactively find high-impact candidates for genomic review.
Preventing An $80k Misstep
- A rheumatoid arthritis patient avoided an ineffective $80k biologic after genomic testing.
- Genomics identified an inexpensive generic (leflunomide) that produced a good clinical response instead.
